Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Mimedx (MDXG) Interest & Investment Income (2023 - 2026)

Mimedx's Interest & Investment Income history spans 4 years, with the latest figure at $886000.0 for Q1 2026.

  • On a quarterly basis, Interest & Investment Income rose 75.1% to $886000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $3.3 million, a 178.4% increase, with the full-year FY2025 number at $2.9 million, up 391.55% from a year prior.
  • Interest & Investment Income hit $886000.0 in Q1 2026 for Mimedx, down from $904000.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for MDXG hit a ceiling of $904000.0 in Q4 2025 and a floor of -$1.7 million in Q1 2024.
  • Historically, Interest & Investment Income has averaged -$174166.7 across 4 years, with a median of $340500.0 in 2024.
  • Biggest five-year swings in Interest & Investment Income: skyrocketed 24500.0% in 2025 and later soared 75.1% in 2026.
  • Tracing MDXG's Interest & Investment Income over 4 years: stood at -$1.6 million in 2023, then surged by 125.3% to $403000.0 in 2024, then soared by 124.32% to $904000.0 in 2025, then dropped by 1.99% to $886000.0 in 2026.
  • Business Quant data shows Interest & Investment Income for MDXG at $886000.0 in Q1 2026, $904000.0 in Q4 2025, and $785000.0 in Q3 2025.